lanadelumab monoclonal antibody drug. targets plasma kallikrein; indicated for treatment of hereditary angioedema. generic name

angioedema antibody biological biosimilar biotech biotechnology breakthrough disease drug hae hereditary immunoglobulin immunology infusion injection inn kallikrein kininogen lanadelumab mab monoclonal nomenclature peptide plasma protein